Crestmont Private Wealth’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.47M Sell
4,466
-403
-8% -$126K 0.41% 17
2026
Q2
$2.11M Sell
4,869
-455
-9% -$138K 0.59% 15
2026
Q1
$1.14M Buy
5,324
+51
+1% +$11.4K 0.36% 18
2025
Q4
$903K Sell
5,273
-396
-7% -$61.6K 0.29% 24
2025
Q3
$759K Buy
5,669
+622
+12% +$65.9K 0.25% 34
2025
Q2
$491K Buy
5,047
+298
+6% +$23.6K 0.18% 45
2025
Q1
$345K Buy
4,749
+1,435
+43% +$113K 0.15% 48
2024
Q4
$239K Buy
3,314
+634
+24% +$48.1K 0.11% 63
2024
Q3
$219K Buy
2,680
+450
+20% +$39.1K 0.1% 93
2024
Q2
$237K Buy
+2,230
New +$214K 0.11% 70

Other funds holding LRCX

Crestmont Private Wealth's LRCX Position: Q3 2026 in Review

Crestmont Private Wealth reduced its Lam Research (LRCX) stake by 8.3% in Q3 2026, selling an estimated $126K and leaving 4,466 shares worth $1.47M. The position accounts for 0.41% of the portfolio, ranked #17.

Crestmont Private Wealth first reported a position in LRCX in Q2 2024 and has held it in 10 quarters since. The position peaked at $2.11M in Q2 2026. 2,274 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

  • Crestmont Private Wealth held 4,466 shares of Lam Research worth $1.47M as of Q3 2026.
  • Crestmont Private Wealth sold 403 Lam Research shares in Q3 2026, an estimated $126K.
  • Lam Research made up 0.41% of Crestmont Private Wealth's portfolio in Q3 2026, its #17 holding.
  • Crestmont Private Wealth first reported a position in Lam Research in Q2 2024 and has held it in 10 quarters since.
  • Crestmont Private Wealth's Lam Research position peaked at $2.11M in Q2 2026.
  • 2,274 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Crestmont Private Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.